Transcode Therapeutics, Inc. (RNAZ) earnings
Quarterly results of Transcode Therapeutics, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Next earnings date
Transcode Therapeutics, Inc. is expected to report around November 13, 2026. That is an estimate from its filing rhythm (the usual gap between its reports), not a date the company has announced.
Latest quarter: Q2 FY2026
In Q2 FY2026 (ended June 30, 2026) Transcode Therapeutics, Inc. reported revenue of - and a net loss of $6.8M.
Diluted earnings per share were -$7.17.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | - | - | -$6.8M | -$7.17 |
| Q1 FY2026 | - | - | -$17.8M | -$21.28 |
| Q4 FY2025 | - | - | -$13.4M | - |
| Q3 FY2025 | - | - | -$4.9M | -$5.82 |
| Q2 FY2025 | - | - | -$4.3M | -$5.13 |
| Q1 FY2025 | - | - | -$12.1M | -$70.16 |
| Q4 FY2024 | - | - | -$5.9M | - |
| Q3 FY2024 | - | - | -$2.3M | -$146.06 |
Results filings
- Quarterly report 10-Q
When is Transcode Therapeutics, Inc.'s next earnings date?
Transcode Therapeutics, Inc. is expected to report around November 13, 2026. That is an estimate from its filing rhythm (the usual gap between its reports), not a date the company has announced.
Get an email when RNAZ reports
Follow RNAZ and we email you its next results the day they are filed, with the numbers explained.